Flyte, a subsidiary of Catheter Precision, Inc. (NYSE American: VTAK), reported preliminary revenue of approximately $640,000 for July 2026, a 102% increase compared to June 2026, according to a press release from the company.

The private aviation platform said July marked its highest revenue month on record. The company attributed the results to its direct-to-consumer booking platform, strategic partnerships, and influencer marketing initiatives.

Since relaunching its direct-to-consumer platform, Flyte said it has acquired more than 2,700 new users. The company operates a fleet of Cirrus Vision Jets and provides private air travel across the United States through its FAA-certified Part 135 subsidiary, Ponderosa Air, LLC.

During 2026, Flyte entered into several partnerships across hospitality, aviation, healthcare, sports, and luxury lifestyle sectors. Partners include helicopter transportation company Blade, Volato's experiential platform Vaunt, Volato AI (NYSE American: SOAR), sports agency GSE Worldwide, PGA Tour professional Emiliano Grillo, airway clearance device maker LifeVac, and East Hampton luxury hotel LDV at The Maidstone.

"Our retail platform is gaining traction, our strategic partnerships are producing measurable customer growth, and our influencer marketing initiatives are accelerating user acquisition," said David Jenkins, Chief Executive Officer of Catheter Precision.

The company noted that the preliminary revenue figures have not been reviewed by its independent registered public accounting firm and remain subject to change pending finalization.